Active Pharmaceutical Ingredients (API) manufacturing
The Free State is keen to develop its pharmaceutical research and development capabilities. Some of the required feedstock for the API facility is currently produced by Sasol, a petrochemical giant based in Sasolburg in Northern Free State. The University of the Free State based in Bloemfontein has also developed an excellent research capability in medical research and biotechnology. The university is currently producing patents in various medical areas.
A private sector investor with good quality API production capability (synthesis process) is intending to establish an Active Pharmaceutical Ingredients (API) facility in the Free State. Good-quality API production is core to the manufacturing of effective and safe essential drugs. Establishing this cluster will provide participants with all the benefits of being located in the SEZ and proximity to natural and industrial resources.
The Free State is looking to recruit a leading latex condom manufacturer to license a South African company in pharmaceuticals and biotechnology to manufacture condoms for the African market. This project will be based in the Tshiame Industrial Estate of the M-SEZ. Conceptual documents have been completed and the estimated capital cost is R370-million.